Slate Therapeutics
Redefining Relief for CRS Patients
StartupSlate Therapeutics is a Tel Aviv-Yafo-based startup in the Health Tech & Life Sciences sector, established in 2021. Redefining Relief for CRS Patients. The company has raised a total of $1M across 1 funding round, currently at the Pre-Seed stage. Slate Therapeutics was founded by Gary Binyamin, Tanhum Feld, Eran Vickus. The company has 1-10 employees.
With $1M in total funding, Slate Therapeutics is a Pre-Seed-stage company operating in Health Tech & Life Sciences. The company follows a B2B2C business model. Product stage: Beta.
- StagePre-Seed
- ProductBeta
- ModelB2B2C
- Employees1-10
- HQTel Aviv-Yafo
- Last Round$1M
Gary BinyaminCo-founder
Tanhum FeldCo-founder
Eran VickusCo-founder & BOD
What does Slate Therapeutics do?
SLATE Therapeutics is dedicated to revolutionizing the treatment of chronic rhinosinusitis (CRS) with SilexGel, a novel sol-gel hydrogel technology. Its mission is to improve patients' quality of life through innovative and effective treatments. SilexGel is a cutting-edge platform technology designed for the systemic and localized delivery of therapeutics. Unlike drug-eluting implants that tend to migrate and cause side effects, or nasal sprays that offer short-term relief, SilexGel provides long-lasting effects with minimal side effects.
How much funding has Slate Therapeutics raised?
Slate Therapeutics has raised $1M in total funding across 1 rounds. The company is currently at the Pre-Seed stage.
Who founded Slate Therapeutics?
Slate Therapeutics was founded in 2021 by Gary Binyamin (Co-founder), Tanhum Feld (Co-founder), Eran Vickus (Co-founder & BOD).
What sector is Slate Therapeutics in?
Slate Therapeutics operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Drug Delivery, Drugs Discovery & Development. Target customers: Healthcare & Life Sciences, Medical Devices Industry, Medical Products, Healthcare, Patients.
Where is Slate Therapeutics located?
Slate Therapeutics is based in Tel Aviv-Yafo, Israel.